This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Genticel. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: **The Innovative Contributions of Yolande Misseri**
Introduction
Yolande Misseri, an esteemed inventor based in Dremil-Lafage, France, has made significant strides in the field of biotechnology. With a portfolio of four patents to her name, she exemplifies the spirit of innovation and dedication to advancing medical science.
Latest Patents
Yolande's recent patents focus on groundbreaking developments in immune response induction through innovative protein designs. The first patent, titled "CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses," describes a chimeric protein that consists of a N-terminal part of the CyaA protein, a heterologous polypeptide, and a C-terminal part of the CyaA protein. This invention includes a polynucleotide encoding a modified version of CyaA, alongside applications for therapeutic and prophylactic compositions utilizing these chimeric proteins.
Her second significant patent, "CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses," presents a method for immunotherapeutic treatment of specific pathological conditions. This invention details a strategy for eliciting T cell immune responses against defined epitopes within the polypeptides, providing both treatment and preventive measures for various diseases through targeted immune memory responses.
Career Highlights
Yolande Misseri currently serves as an innovator at Genticel, a company recognized for its commitment to pioneering medical technologies. Her work consistently reflects her dedication to enhancing therapeutic options and contributing to public health through innovative research and development.
Collaborations
Throughout her career, Yolande has worked alongside prominent colleagues, including Michael Esquerre and Etienne Joly, fostering a collaborative environment that promotes the sharing of ideas and expertise in scientific advancements. These partnerships have been instrumental in refining her inventions and expediting their development.
Conclusion
Yolande Misseri's contributions to the field of biotechnology are a testament to her innovative spirit and commitment to improving health outcomes through research. Her patents not only reflect her expertise but also promise to play vital roles in shaping future therapeutic strategies. As she continues her work with Genticel, the impact of her innovations will undoubtedly resonate within the scientific community and beyond.